NRX Pharmaceuticals (NRXP) EBITDA (2020 - 2026)
NRX Pharmaceuticals (NRXP) posted EBITDA of -$6.43 million for Q2 2026, compared with -$3.73 million a year earlier.
Powered by 
Analysis
NRX Pharmaceuticals (NRXP) EBITDA (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at NRX Pharmaceuticals was -$19.69 million; for FY2025, it came in at -$16.15 million.
- In prior years, NRX Pharmaceuticals' EBITDA was -$18.5 million in FY2024, -$27.83 million in FY2023, -$44.33 million in FY2022 and -$115.79 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly EBITDA since Q2 2024.
- According to Business Quant data, EBITDA for the three prior quarters was -$4.68 million (Q1 2026), -$4.58 million (Q4 2025) and -$4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.30 Bn |
| 10 | NRX Pharmaceuticals | 126.02 Mn | 77.61 Mn | 426,000.00 | -6.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.43 Mn |
| Mar 31, 2026 | -4.68 Mn |
| Dec 31, 2025 | -4.58 Mn |
| Sep 30, 2025 | -4.00 Mn |
| Jun 30, 2025 | -3.73 Mn |
| Mar 31, 2025 | -3.85 Mn |
| Dec 31, 2024 | -2.43 Mn |
| Sep 30, 2024 | -3.02 Mn |
| Jun 30, 2024 | -7.05 Mn |
| Mar 31, 2024 | -6.00 Mn |
| Dec 31, 2023 | -4.41 Mn |
| Sep 30, 2023 | -5.81 Mn |
| Jun 30, 2023 | -8.19 Mn |
| Mar 31, 2023 | -3.85 Mn |
| Dec 31, 2022 | -9.89 Mn |
| Sep 30, 2022 | -9.14 Mn |
| Jun 30, 2022 | -9.60 Mn |
| Mar 31, 2022 | -15.70 Mn |
| Dec 31, 2021 | -52.98 Mn |
| Sep 30, 2021 | -20.10 Mn |
API Access
NRX Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=NRXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "NRXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=NRXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();